Adjacent segment disease after minimally invasive transforaminal lumbar interbody fusion for degenerative lumbar diseases: incidence and risk factors

被引:13
|
作者
Yuan, Chao [1 ]
Zhou, Jing [2 ]
Wang, Liran [2 ]
Deng, Zhongliang [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Orthopaed, 76 Linjiang Rd, Chongqing 400010, Peoples R China
[2] Army Med Univ, Affiliated Xinqiao Hosp, Dept Orthopaed Surg, 183 Xingiao St, Chongqing 183, Peoples R China
关键词
Adjacent segment disease; Minimally invasive transforaminal lumbar interbody fusion; Degenerative lumbar diseases; Risk factors; INTERVERTEBRAL DISC DEGENERATION; SURGERY; INSTRUMENTATION; SMOKING; MUSCLE; TERM;
D O I
10.1186/s12891-022-05905-6
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Study design Retrospective study. Objectives To explore the incidence and risk factors for symptomatic adjacent segment disease (ASD) in patients enveloped in degenerative lumbar diseases after minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF). Methods Data were retrospectively analyzed on 744 patients who underwent MIS-TLIF for degenerative lumbar diseases in our hospital from October 2012 to December 2018. The patients were divided into the ASD group and non-ASD (N-ASD) group on the basis of developing ASD at follow-up, and then the incidence of ASD was calculated. Clinical and radiological risk factors were assessed over time to determine their association with ASD by excluding less important factors. Results Data were missing for 26 patients, while a total of 718 patients were successfully monitored after MIS-TLIF. Of the 718 individuals participated in the study, 34 (4.7%) patients plagued by ASD required surgical intervention. The average onset time of ASD was 62.7 +/- 15.1 months. Univariate analysis results shows that age, bone mineral density (BMD), body mass index (BMI), preoperative adjacent intervertebral disc height and preoperative adjacent segment disc degeneration were significantly different between the ASD and N-ASD groups (p < 0.05). The logistic regression analysis results demonstrated that BMD (p = 0.039, OR = 0.986, 95% CI 0.899-1.115), BMI (p = 0.041, OR = 1.119, 95% CI 1.103-2.397), and preoperative adjacent intervertebral disc degeneration (p = 0.023, OR = 1.215, 95% CI 1.015-1.986) may be seen as risk factors for ASD after MIS-TLIF. Conclusions The incidence of ASD was about 4.7% in patients suffer from degenerative lumbar diseases after MIS-TLIF. BMD, BMI and preoperative adjacent intervertebral disc degeneration might be the risk factors for the occurrence of ASD after MIS-TLIF. Our research also suggested that patients with lower BMD, higher BMI and disc preoperative adjacent segment disc degeneration were more likely to develop ASD after MIS-TLIF.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Comparing the efficacy of unilateral biportal endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion in lumbar degenerative diseases: a systematic review and meta-analysis
    Haopeng Luan
    Cong Peng
    Kai Liu
    Xinghua Song
    Journal of Orthopaedic Surgery and Research, 18
  • [42] Minimally invasive surgery for degenerative spondylolisthesis: transforaminal or oblique lumbar interbody fusion
    Sheng, Sun-Ren
    Geng, Yi-Bo
    Zhou, Kai-Liang
    Wu, Ai-Min
    Wang, Xiang-Yang
    Ni, Wen-Fei
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (01) : 45 - 51
  • [43] Surgery for degenerative lumbar disease: transforaminal lumbar interbody fusion
    Dieter Grob
    European Spine Journal, 2009, 18 : 1991 - 1992
  • [44] Clinical outcomes after minimally invasive transforaminal lumbar interbody fusion and lateral lumbar interbody fusion for treatment of degenerative lumbar disease: a systematic review and meta-analysis
    Gun Keorochana
    Kitipong Setrkraising
    Patarawan Woratanarat
    Alisara Arirachakaran
    Jatupon Kongtharvonskul
    Neurosurgical Review, 2018, 41 : 755 - 770
  • [45] Clinical outcomes after minimally invasive transforaminal lumbar interbody fusion and lateral lumbar interbody fusion for treatment of degenerative lumbar disease: a systematic review and meta-analysis
    Keorochana, Gun
    Setrkraising, Kitipong
    Woratanarat, Patarawan
    Arirachakaran, Alisara
    Kongtharvonskul, Jatupon
    NEUROSURGICAL REVIEW, 2018, 41 (03) : 755 - 770
  • [46] Comparison of the Outcomes of Minimally Invasive Transforaminal Lumbar Interbody Fusion and Endoscopic Transforaminal Lumbar Interbody Fusion for Lumbar Diseases: A Matched Case-Control
    Shi, Liang
    Ding, Tao
    Shi, Yihua
    Wang, Fang
    Wu, Chengcong
    WORLD NEUROSURGERY, 2022, 167 : E1231 - E1240
  • [47] Minimally Invasive Transforaminal Lumbar Interbody Fusion and Lateral Interbody Fusion
    Stadler, James A., III
    Dandaleh, Nader S.
    Smith, Zachary A.
    Koski, Tyler R.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2014, 25 (02) : 377 - +
  • [48] Sagittal Alignment as Predictor of Adjacent Segment Disease After Lumbar Transforaminal Interbody Fusion
    Sun, Jin
    Wang, Jun-Jie
    Zhang, Li-wei
    Huang, Hui
    Fu, Na-xin
    WORLD NEUROSURGERY, 2018, 110 : E567 - E571
  • [49] Comparison of Outcomes Between Endoscopic Transforaminal Lumbar Interbody Fusion and Minimally Invasive Transforaminal Lumbar Interbody Fusion in Patients With Single-Level Lumbar Degenerative Disease: A Retrospective Study
    Xu, Hongyao
    Yu, Lei
    Xiao, Bing
    Zhao, Hong
    Gu, Xin
    Gao, Zengxin
    Wang, Weiheng
    WORLD NEUROSURGERY, 2024, 183 : E98 - E108
  • [50] Lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study
    Xue, You-Di
    Diao, Wen-Bo
    Ma, Chao
    Li, Jie
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2021, 16 (01)